VectivBio Holding AG

NASDAQ: VECT · Real-Time Price · USD
16.87
0.02 (0.12%)
At close: Jul 07, 2023, 9:59 PM

VectivBio Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
676K n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a
Gross Profit
676K n/a n/a n/a n/a
Operating Income
-72.01M -86.91M -80.03M -73.15M -66.27M
Interest Income
n/a n/a n/a n/a n/a
Pretax Income
-72M -86.94M -80.19M -73.44M -66.69M
Net Income
-71.98M -87.01M -80.38M -73.75M -67.13M
Selling & General & Admin
24.96M 35.81M 30.36M 24.91M 19.47M
Research & Development
-86.5M 50.18M 48.39M 46.61M 44.82M
Other Expenses
-21.96M -172.9M -158.78M -144.67M -130.56M
Operating Expenses
-83.5M -86.91M -80.03M -73.15M -66.27M
Interest Expense
-9K 36K 165.5K 295K 424.5K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
3.32M 86.72M 79.35M 71.99M 64.62M
Income Tax Expense
-16K 64K 186.5K 309K 431.5K
Shares Outstanding (Basic)
44.13M 26.96M 26.96M 26.96M 26.96M
Shares Outstanding (Diluted)
44.13M 26.96M 26.96M 26.96M 26.96M
EPS (Basic)
-2.27 -3.24 -3.08 -2.92 -2.76
EPS (Diluted)
-2.27 -3.24 -3.08 -2.92 -2.76
EBITDA
-72.04M -86.79M -79.92M -73.04M -66.17M
EBIT
-72.01M -86.91M -80.03M -73.15M -66.27M
Depreciation & Amortization
-29.25K 117K 112.25K 107.5K 102.75K